Literature DB >> 14700633

GSK-3-selective inhibitors derived from Tyrian purple indirubins.

Laurent Meijer1, Alexios-Leandros Skaltsounis, Prokopios Magiatis, Panagiotis Polychronopoulos, Marie Knockaert, Maryse Leost, Xiaozhou P Ryan, Claudia Alin Vonica, Ali Brivanlou, Rana Dajani, Claudia Crovace, Cataldo Tarricone, Andrea Musacchio, S Mark Roe, Laurence Pearl, Paul Greengard.   

Abstract

Gastropod mollusks have been used for over 2500 years to produce the "Tyrian purple" dye made famous by the Phoenicians. This dye is constituted of mixed bromine-substituted indigo and indirubin isomers. Among these, the new natural product 6-bromoindirubin and its synthetic, cell-permeable derivative, 6-bromoindirubin-3'-oxime (BIO), display remarkable selective inhibition of glycogen synthase kinase-3 (GSK-3). Cocrystal structure of GSK-3beta/BIO and CDK5/p25/indirubin-3'-oxime were resolved, providing a detailed view of indirubins' interactions within the ATP binding pocket of these kinases. BIO but not 1-methyl-BIO, its kinase inactive analog, also inhibited the phosphorylation on Tyr276/216, a GSK-3alpha/beta activation site. BIO but not 1-methyl-BIO reduced beta-catenin phosphorylation on a GSK-3-specific site in cellular models. BIO but not 1-methyl-BIO closely mimicked Wnt signaling in Xenopus embryos. 6-bromoindirubins thus provide a new scaffold for the development of selective and potent pharmacological inhibitors of GSK-3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14700633     DOI: 10.1016/j.chembiol.2003.11.010

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  242 in total

1.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

2.  Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.

Authors:  Kylene Kehn-Hall; Irene Guendel; Lawrence Carpio; Leandros Skaltsounis; Laurent Meijer; Lena Al-Harthi; Joseph P Steiner; Avindra Nath; Olaf Kutsch; Fatah Kashanchi
Journal:  Virology       Date:  2011-04-22       Impact factor: 3.616

3.  Wnt/beta-catenin signalling regulates cardiomyogenesis via GATA transcription factors.

Authors:  Jennifer Martin; Boni A Afouda; Stefan Hoppler
Journal:  J Anat       Date:  2010-01       Impact factor: 2.610

4.  Cdc42 and Gsk3 modulate the dynamics of radial glial growth, inter-radial glial interactions and polarity in the developing cerebral cortex.

Authors:  Yukako Yokota; Tae-Yeon Eom; Amelia Stanco; Woo-Yang Kim; Sarada Rao; William D Snider; E S Anton
Journal:  Development       Date:  2010-12       Impact factor: 6.868

Review 5.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

Review 6.  Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach.

Authors:  Wei Chen; Minyong Chen; Larry S Barak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-27       Impact factor: 4.052

7.  A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient βcatenin destruction.

Authors:  Mira I Pronobis; Nasser M Rusan; Mark Peifer
Journal:  Elife       Date:  2015-09-22       Impact factor: 8.140

8.  Antagonism between Hedgehog and Wnt signaling pathways regulates tumorigenicity.

Authors:  Mei Ding; Xin Wang
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

9.  Evidence that fold-change, and not absolute level, of beta-catenin dictates Wnt signaling.

Authors:  Lea Goentoro; Marc W Kirschner
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

10.  Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.

Authors:  Konstantina Vougogiannopoulou; Yoan Ferandin; Karima Bettayeb; Vassilios Myrianthopoulos; Olivier Lozach; Yunzhen Fan; Carl Hirschie Johnson; Prokopios Magiatis; Alexios-Leandros Skaltsounis; Emmanuel Mikros; Laurent Meijer
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.